StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3011% below fair value
$0.82+0.00 (+0.35%)

Close on Nov 16, 2026Market cap $36.45MP/E –Yield –

Elutia total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Elutia's total debt was $31.10M at Sep 30, 2025. For fiscal 2024 it was $25.10M, down 7.0% from the year before. The highest annual figure on record is $30.43M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$25.10M-7.0%
FY2023Dec 31, 2023$27.00M+11.3%
FY2022Dec 31, 2022$24.26M-8.5%
FY2021Dec 31, 2021$26.53M-12.8%
FY2020Dec 31, 2020$30.43M+42.8%
FY2019Dec 31, 2019$21.30M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$31.10M+37.4%
Q2 FY2025Jun 30, 2025$28.87M+12.0%
Q1 FY2025Mar 31, 2025$26.76M+10.2%
Q4 FY2024Dec 31, 2024$25.10M-7.0%
Q3 FY2024Sep 30, 2024$22.64M-10.4%
Q2 FY2024Jun 30, 2024$25.77M+3.4%
Q1 FY2024Mar 31, 2024$24.29M-1.2%
Q4 FY2023Dec 31, 2023$27.00M+11.3%
Q3 FY2023Sep 30, 2023$25.28M+8.8%
Q2 FY2023Jun 30, 2023$24.93M+0.2%
Q1 FY2023Mar 31, 2023$24.59M-7.3%
Q4 FY2022Dec 31, 2022$24.26M-13.9%
Q2 FY2022Jun 30, 2022$23.22M-19.1%
Q1 FY2022Mar 31, 2022$24.88M-24.1%
Q4 FY2021Dec 31, 2021$26.53M-12.8%
Q3 FY2021Sep 30, 2021$28.16M+16.9%
Q2 FY2021Jun 30, 2021$28.69M+34.7%
Q1 FY2021Mar 31, 2021$32.77M–
Q4 FY2020Dec 31, 2020$30.43M–
Q3 FY2020Sep 30, 2020$24.09M–
Q4 FY2019Dec 31, 2019$21.30M–

More Elutia figures

See a number that looks wrong?